This website uses cookies to distinguish you from other users. This helps us to provide you with a good user experience and also allows us to improve our website. Privacy & Cookies Policy
Colleen Cunningham
Assistant Professor of Strategy and Entrepreneurship
BA (University of British Columbia) MA (Simon Fraser University) PhD (Duke University)
Dr Colleen Cunningham’s research examines the challenges and advantages of commercialising new-to-the-world inventions. Dr Cunningham is fascinated by markets for technology, specifically the origins of markets and their role in the selection of novel ideas. Her research also focuses on anti-competitive motivations for technology acquisitions. Her specialism spans high technology innovation and entrepreneurship, focusing in particular on medical technologies such as medical devices and pharmaceuticals.
Prior to academia, Dr Cunningham was a health policy researcher, publishing 12 peer-reviewed articles on health systems management and policy related to pharmaceuticals, and drafting advisory reports for various stakeholders, including health system managers. Dr Cunningham also worked as a consulting researcher for the Economic Development department of the Government of British Columbia (Canada), in the oil and gas industry, and in natural resource management.
- ccunningham@london.edu
- +44 (0)20 7000 8154
- Colleen Cunningham CV
Awards and Honours
- Sumantra Ghoshal Research and Practice Award, Strategic Management Division, Academy of Management, 2018.
- Western Finance Association CRA Corporate Finance Best Paper Award, 2018.
- Mark A Satterthwaite Health Care Markets Best Paper Prize, 2018.
- Best Dissertation Award (finalist), Strategic Management Division, Academy of Management, 2018.
- Kauffman Foundation Dissertation Fellowship, 2017.
- Fulbright Canada Student Award, 2011-2012.
- Simon Fraser University Graduate Fellowship Award, 2007.
- Innovation and technology strategy
- Markets for ideas, technology, and firms
- Competition and innovation
- Health innovation and entrepreneurship
- Health care management and policy
- Interfirm relationships
2019
Experimenting strategically: Inter-firm relationships and “in-the-field” innovation
Kapacinskaite A; Cunningham C
Academy of Management Proceedings 2019 Vol 2019:1
The limits of relational governance: sales force strategies in the US medical device industry
Chatterji AK; Cunningham C M; Joseph JE
Strategic Management Journal 2019 Vol 40:1 p 55-78
2013
Racial and ethnic disparities in the use of antipsychotic medicatication: a systematic review and meta-analysis
Puyat J H; Daw J R; Cunningham C M; Law M R; Wong T W; Greyson D L; Morgan S G
Social Psychiatry and Psychiatric Epidemiology 2013 Vol 48:12 p 1861-1872
2012
Drug development: innovation or imitation deficit?
Morgan S G; Cunningham C M; Law M R
British Medical Journal 2012 Vol 345
Information behaviour of Canadian pharmaceutical policy makers
Greyson D L; Cunningham C M; Morgan S
Health Information and Libraries Journal 2012 Vol 29:1 p 16-27
2011
Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data
Morgan S; Hanley G; Cunningham C M; Quan H
Open Medicine 2011 Vol 5:2 p e87-e92
Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study
Puyat J H; Hanley G E; Cunningham C M; Law M R; Wong S T; Sutherland J M; Morgan S G
Psychiatric Services 2011 Vol 62:9 p 1026-1031
Income inequities in end-of-life health care spending in British Columbia, Canada: a cross-sectional analysis, 2004-2006
Cunningham C M; Hanley G E; Morgan S G
International Journal for Equity in Health 2011 Vol 10:12
Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in British Columbia, 1996 to 2006
Morgan S; Cunningham C M
Healthcare Policy 2011 Vol 7:1 p 68-79
The cost of drug development: a systematic review
Morgan S; Grootendorst P; Lexchin J; Cunningham C M; Greyson D
Health Policy 2011 Vol 100:1 p 4-17
2010
Individual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British Columbia
Morgan S G; Cunningham C M; Hanley G E
PLoS ONE 2010
Listening for prescriptions: a national consultation on pharmaceutical policy issues
Morgan S; Cunningham C M
Healthcare Policy 2010 Vol 6:2 p 48-66
Patterns in the use of benzodiazepines in British Columbia: Examining the impact of increasing research and guideline cautions against long-term use
Cunningham C M; Hanley G E; Morgan S G
Health Policy 2010 Vol 97:2-3 p 122-129
2009
The British Columbia medical and hospital atlas : a companion to the British Columbia Rx atlas, 2nd edition
Morgan S; Cunningham C M; Hanley G; Mooney D
Centre for Health Services and Policy Research (CHSPR)
The British Columbia Rx atlas, 2nd edition
Morgan S; Cunningham C M; Hanley G; Mooney D
Centre for Health Services and Policy Research (CHSPR)
2008
The effect of evidence-based drug coverage policies on pharmaceutical R&D: a case study from British Columbia
Morgan S; Cunningham C M
Healthcare Policy 2008 Vol 3:3 p e128-e153
2018
Inventive capabilities in the division of innovative labor
Arora A; Cohen W M; Cunningham C M
NBER Working Paper
Teaching portfolio
Our teaching offering is updated annually. Faculty and programme material are subject to change.
Core courses
- Strategy